Melatonin influences antioxidant homeostasis and basal metabolism in the BALB/c mouse model

Neuroendocrinology Letters

Volumn 33, Issue SUPPL. 3, 2012, Pages 183-189

  Pohanka, Miroslav ^a   Bandouchova, Hana ^b   Pikula, Jiri ^b  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

^b UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

Author keywords

Antioxidant; Apoptosis; Glucose; High density lipoprotein; Melatonin; Oxidative stress; Pineal gland

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; CASPASE 3; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MELATONIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BASAL METABOLIC RATE; BRAIN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; ENZYME ACTIVITY; FEMALE; HEART; HOMEOSTASIS; KIDNEY; LIVER; MOLECULAR WEIGHT; MOUSE; NONHUMAN; OXIDATIVE STRESS; SPLEEN;

EID: 84874812905     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Cuesta S, Kireev R, Garcia C, Rancan L, Vara E, Tresquerres JA (2012) Melatonin can improve insulin resistance and aging-induced pancreas alterations in senescence-accelerated prone male mice (SAMP8). Age (Dordr), In press.
2. Dikmernoglu N, Ileri E, Seringec N, Ercil D (2008) Melatonin prevents lipid peroxidation in human erythrocytes but augments deterioration of deformability after in vitro oxidative stress. Clin Hemorheol Microcirc 40: 235-242.
3. Fellenberg AJ, Phillpou G, Seamark RF (1980) Measurement of urinary production rates of melatonin as an index of human pineal function. Endocr Res Commun 7: 167-175. (Pubitemid 10062513)
4. Gooneratne NS, Edwards AY, Zhou C, Cuellar N, Grandner MA, Barrett JS (2012) Melatonin pharmacokinetics following two different oral surge-sustained release doses in older adults. J Pineal Res 52: 437-445.
5. Hill SM, Frasch T, Xiang S, Yuan L, Duplessis T, Mao L (2009) Molecular mechanisms of melatonin anticancer effects. Integr Cancer Ther 8: 337-346.
6. Imbesi M, Uz T, Dzitoyeva S, Giusti P, Manev H (2008) Melatonin signaling in mouse cerebellar granule cells with variable native MT1 and MT2 melatonin. Brain Res 1227: 19-25.
7. Imbesi M, Arslan AD, Yildiz S, Sharma R, Gavin D, Tun N, Manev H, Uz T (2009) The melatonin receptor MT1 is required for the differential regulatory actions of melatonin on neuronal "clock" gene expression in striatal neurons in vitro. J Pineal Res 46: 87-94.
8. Kitagawa A, Ohta Y, Ohashi K (2012) Melatonin improves metabolic syndrome induced by high fructose intake in rats. J Pineal Res 52: 403-413.
9. Korkmaz A, Ma S, Topal T, Rosales-Corral S, Tan DX, Reiter RJ (2012) Glucose: a vital toxin and potential utility of melatonin in protecting against the diabetic state. Mol Cell Endocrinol 349: 128-137.
10. Kunak ZE, Macit E, Yaren H, Cakir E, Aydin I, Turker T, Kurt YG, Ozcan A, Uysal B, Isbilir S, Akgul EO, Cayci T, Korkmaz A, Kenar L (2012) Protective effects of melatonin and S-methylisothiourea on mechlorethamine induced nephrotoxicity. J Surg Res 175: 17-23.
11. Kurus M, Esrefoglu M, Sogutlu G, Atasever A (2009) Melatonin prevents cyclosporine-induced hepatotoxicity in rats. Med Princ Pract 18: 407-410.
12. Lemoine P, Wade AG, Katz A, Nir T, Zisapel N (2012) Efficacy and safety of prolonged-release melatonin for insomnia in middle-aged and elderly patients with hypertension: a combined analysis of controlled clinical trials. Integr Blood Press Control 5: 9-17.
13. Liu Y, Zhang L, Zhang H, Liu B, Wu Z, Zhao W, Wang Z (2012) Exogenous melatonin modulates apoptosis in the mouse brain induced by high-LET carbon ion irradiation. J Pineal Res 52: 47-56.
14. Lykkesfeldt J (2007) Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking. Clin Chim Acta 380: 50-58.
15. Maharaj DS, Glass BD, Daya S (2007) Melatonin: new places in therapy. Biosci Rep. 27: 299-320. (Pubitemid 350163713)
16. Martin U (2007) Neuronal cell death in nervous system development, disease, and injury (review). Int J Mol Med 7: 455-478.
17. McArthur AJ, Budden SS (1998) Sleep dysfunction in Rett syndrome: a trial of exogenous melatonin treatment. Dev Med Child Neurol 40: 186-192. (Pubitemid 28132696)
18. Murray P, Udani S, Koyner JL (2011) Does replacement therapy improve outcome? Controversies in acute kidney injury. Contrib Nephrol 174: 212-221.
19. Nagato AC, Bezerra FS, Lanzetti M, Lopes AA, Silva MA, Porto LC, Valenca SS (2012) Time course of inflammation, oxidative stress and tissue damage induced by hyperoxia in mouse lungs. Int J Exp Pathol 93: 269-278.
20. Nduhirabandi F, du Toit EF, Lochner A (2012) Melatonin and the metabolic syndrome: a tool for effective therapy in obesity-associated abnormalities? Acta Physiol (Oxf.) 205: 209-223.
21. Oliveira AC, Andreotti S, Farias TD, Torres-Leal FL, de Proenca AR, Campana AB, de Souza AH, Sertie RA, Carpinelli AR, Cipolla-Neto J, Lima FB (2012) Metabolic disorders and adipose tissue insulin responsiveness in neonatally STZ-induced diabetic rats are improved by long-term melatonin treatment. Endocrinology 153: 2178-2188.
22. Orendas P, Kubatka P, Kaio K, Stollarova N, Kassayova M, Bojkova B, Pec M, Nosal V, Kiskova T, Zihlavnikova K, Karsnakova (2012) Melatonin enhanced baxarotene efficacy in experimental mammary carcinogenesis. Neoplasma 59: 469-474.
23. Patschan D, Hildebrandt A, Rinneburger J, Wessels JT, Patchan SA, Becker JU, Henze E, Hruger A, Muller GA (2012) The hormone melatonin stimulates renoprotective effects of early outgrowth endothelial progenitor cells in acute ischemic kidney injury. Am J Physiol Renal Physiol 302: 1305-1312.
24. Pohanka M, Bandouchova H, Sobotka J, Sedlackova J, Soukupova I, Pikula J (2009) Comparison of ferric reducing antioxidant power and square wave voltammetry for assay of low molecular weight antioxidants in blood plasma: performance and comparison of methods. Sensors 9: 9094-9103.
25. Pohanka M (2011) Alzheimer's disease and related neurodegenerative disorders: implication and counteracting of melatonin. J Appl Biomed 9: 185-196.
26. Pohanka M, Sobotka J, Stetina R (2011a) Sulfur mustard induced oxidative stress and its alteration by epigallocatechin gallate. Toxicol Lett 201: 105-109.
27. Pohanka M, Sobotka J, Svobodova J, Stetina R (2011b) Investigation of oxidative stress in blood, brain, kidney, and liver after oxime antidote HI-6 application in a mouse experimental model. Drug Chem Toxicol 34: 255-260.
28. Pohanka M, Sobotka J, Jilkova M, Stetina R (2011c) Oxidative stress after sulfur mustard intoxication and its reduction by melatonin: efficacy of antioxidant therapy during serious intoxication. Drug Chem Toxicol 34: 85-91.
29. Pyles LA, Stejskal EJ, Einzig S (1993) Spectrophotometric measurement of plasma 2-thiobarbituric acid-reactive substances in the presence of hemoglobin and bilirubin interference. Proc Soc Exp Biol Med 202: 407-419. (Pubitemid 23097831)
30. Silva CL, Tamura EK, Macedo SM, Cecon E, Bueno-Alves L, Farsky SH, Ferreira ZS, Markus RP (2007) Melatonin inhibits nitric oxide production by microvascular endothelial cells in vivo and in vitro. Br J Pharmacol 151: 195-205. (Pubitemid 46763046)
31. Siri-Tarino PW (2011) Effects of diet on high-density lipoprotein cholesterol. Curr Atheroscler Rep 13: 453-460.
32. Tan DX, Manchester LC, Terron MP, Flores LJ, Reiter RJ (2007) One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 42: 28-42. (Pubitemid 44924323)
33. Tunez L, Munoz MC, Feijoo-Lopez AL, Valdvira E, Bujalance-Arenas L, Montilla P (2002) Effect of melatonin on hyperlipidemic nephropathy under constant light exposure. J Physiol Biochem 58: 109-114. (Pubitemid 35230086)
34. Tunstall RR, Shukla P, Grazul-Bilska A, Sun C, O'Rourke ST (2011) MT2 receptors mediate the inhibitory effects of melatonin on nitric oxide-induced relaxation of porcine isolated coronary arteries. J Pharmacol Exp Ther 336: 127-133.
35. Vlassi M, Gazouli M, Paltoglou G, Christopoulos P, Florentin L, Kassi G, Mastorakos G (2012) The rs10830963 variant of melatonin receptor MTNR1B is associated with increased risk for gestational diabetes mellitus in a Greek population. Hormones (Athens) 11: 70-76.
36. Wang Z, Liu D, Wang J, Liu S, Gao M, Ling EA, Hao A (2012a) Cytoprotective effects of melatonin on astroglial cells subjected to palmitic acid treatment in vitro. J Pineal Res 52: 253-264.
37. Wang J, Xiao X, Zhang Y, Shi D, Chen W, Fu L, Liu L, Xie F, Kang T, Huang W, Deng W (2012) Simultaneous modulation of COX-2, p300, Akt, and Afap-1 signaling by melatonin to inhibit proliferation and induce apoptosis in breast cancer cells. J Pineal Res 53: 77-90.
38. Watanabe K, Hamada F, Wakatsuki A, Nagai R, Shinohara K, Hayashi Y, Imamura R, Fukaya T (2012) Prophylactic administration of melatonin to the mother throughout pregnancy can protect against oxidative cerebral damage in neonatal rats. J Matern Fetal Neonatal Med 25: 1254-1259.
39. Wu CC, Lu KC, Lin GJ, Hsieh HY, Chu P, Lin SH, Sytwu HK (2012) Melatonin enhances endogenous heme oxygenase-1 and represses immune responses to ameliorate experimental murine membranous nephropathy. J Pineal Res 52: 460-469.
40. Zarazaga LA, Celi I, Guzman JL, Malpaux B (2010) Melatonin concentrations in the two jugular veins, and relationship with the seasonal reproductive activity in goats. Theriogenelogy 74: 221-228.
41. Zhou QP, Jung L, Richards KC (2012) The management of sleep and circadian disturbance in patients with dementia. Curr Neurol Neurosci Rep 12: 193-204.